{"id":44648,"date":"2026-02-15T04:08:44","date_gmt":"2026-02-15T04:08:44","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/blood-disorder-therapeutics-market-mordor\/"},"modified":"2026-04-03T12:29:53","modified_gmt":"2026-04-03T03:29:53","slug":"blood-disorder-therapeutics-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/blood-disorder-therapeutics-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d \u2013 \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/blood-disorders-market__Blood_Disorders_Market_Players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/blood-disorder-therapeutics-market-size-image-1768931037591.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \uc5ed\ud559<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \ub2e4\uc591\ud55c \ud608\uc561 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc120\uc9c4 \uce58\ub8cc \uc635\uc158\uc744 \uc704\ud55c R&amp;D \ud22c\uc790 \uc99d\uac00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \uce58\ub8cc \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc5c4\uaca9\ud55c \uaddc\uc81c \uae30\uc900<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.4.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.2 \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uc138\ubd84\ud654<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc81c\ud488 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ud608\uc7a5 \uc720\ub798 \uc778\uc790<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc7ac\uc870\ud569 \uc778\uc790<\/li>\n<li class=\"toc-level-3\">5.1.3 \uae30\ud0c0 \uc81c\ud488<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud5e4\ubaa8\uae00\ub85c\ube48 \uc7a5\uc560<\/li>\n<li class=\"toc-level-3\">5.2.2 \ud608\uc18c\ud310 \uae30\ubc18 \uc7a5\uc560<\/li>\n<li class=\"toc-level-3\">5.2.3 \ud608\uc7a5 \uc7a5\uc560<\/li>\n<li class=\"toc-level-3\">5.2.4 \uace8\uc218\uc99d\uc2dd\uc131 \uc7a5\uc560<\/li>\n<li class=\"toc-level-3\">5.2.5 \uc720\uc804\uc131 \ud608\uc561\ud559\uc801 \uc7a5\uc560<\/li>\n<li class=\"toc-level-3\">5.2.6 \ud608\uc561\uc554<\/li>\n<li class=\"toc-level-3\">5.2.7 \uae30\ud0c0 \uc801\uc6a9 \ubd84\uc57c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.3.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.3.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.3.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.3.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.3.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.3.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.3.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.3.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.3.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.3.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.3.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.3.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.3.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.3.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd<\/p>\n<p># 1. \uc11c\ub860<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uae00\ub85c\ubc8c \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \ud604\uc7ac \ub3d9\ud5a5, \uc2dc\uc7a5 \uc810\uc720\uc728, \uc131\uc7a5\ub960 \ubc0f \uaddc\ubaa8\uc5d0 \ub300\ud55c \uc2ec\uce35 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ud2b9\ud788 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc2dc\uc7a5\uc758 \uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825\uacfc \ud1b5\ucc30\ub825\uc744 \uc81c\uc2dc\ud558\uba70, \uc81c\ud488 \uc720\ud615, \uc801\uc6a9 \ubd84\uc57c \ubc0f \uc9c0\uc5ed\ubcc4 \uc138\ubd84\ud654\ub97c \ud1b5\ud574 \uc2dc\uc7a5\uc758 \ub2e4\uac01\uc801\uc778 \uce21\uba74\uc744 \uc870\uba85\ud569\ub2c8\ub2e4.<\/p>\n<p># 2. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \uc9c0\ud45c<\/p>\n<p>Mordor Intelligence\uc758 \ubd84\uc11d\uc5d0 \ub530\ub974\uba74, \uae00\ub85c\ubc8c \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 6.13%\uc758 \uacac\uc870\ud55c \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ubcf8 \uc5f0\uad6c\ub294 2020\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \uae30\uac04\uc744 \ub2e4\ub8e8\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \uc608\uce21 \ub370\uc774\ud130\uc640 2020\ub144\ubd80\ud130 2024\ub144\uae4c\uc9c0\uc758 \uc5ed\uc0ac\uc801 \ub370\uc774\ud130\ub97c \ud3ec\ud568\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4 \uc2dc\uc7a5 \ub3d9\ud5a5\uc744 \uc0b4\ud3b4\ubcf4\uba74, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc73c\ub85c \ubd80\uc0c1\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub418\uba70, \ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<\/p>\n<p>\ud604\uc7ac \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\ub294 \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi, Novo Nordisk A\/S, CSL Ltd, Pfizer Inc, Bayer AG, Celgene Corporation, Alexion Pharmaceuticals, Inc, Amgen Inc, AstraZeneca Plc \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. (\uc8fc\uc694 \uae30\uc5c5\uc740 \ud2b9\uc815 \uc21c\uc11c \uc5c6\uc774 \ub098\uc5f4\ub418\uc5c8\uc2b5\ub2c8\ub2e4.)<\/p>\n<p># 3. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30<\/p>\n<p> 3.1. \uc7ac\uc870\ud569 \uc778\uc790(Recombinant Factors) \ubd80\ubb38\uc758 \uc911\uc694\uc131 \uc99d\ub300<\/p>\n<p>\uc7ac\uc870\ud569 \uc778\uc790 \ubd80\ubb38\uc740 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ud608\uc561 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\uc640 \uc7ac\uc870\ud569 \uc778\uc790 \ub18d\ucd95\uc561\uc758 \ucc44\ud0dd \ud655\ub300\uc5d0 \ud798\uc785\uc5b4 \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\uc11c \uc0c1\ub2f9\ud55c \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc7ac\uc870\ud569 \uc778\uc790\ub294 \uc7ac\uc870\ud569 \uae30\uc220\uc744 \ud1b5\ud574 \uc81c\uc870\ub418\ub294 \ud608\uc561 \uc778\uc790\uc758 \ud55c \ud615\ud0dc\ub85c, \ud608\uc6b0\ubcd1\uacfc \uac19\uc740 \ucd9c\ud608\uc131 \uc9c8\ud658\uc758 \uc608\ubc29 \ubc0f \uce58\ub8cc\uc5d0 \ud544\uc218\uc801\uc73c\ub85c \uc0ac\uc6a9\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc138\uacc4\ud608\uc6b0\ubcd1\uc5f0\ub9f9(World Federation of Hemophilia) \ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, 2017\ub144 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc57d 315,423\uba85\uc774 \ucd9c\ud608\uc131 \uc9c8\ud658\uc744 \uc553\uace0 \uc788\uc73c\uba70, \uc774 \uc911 \uc57d 196,706\uba85\uc774 \ud608\uc6b0\ubcd1, 76,144\uba85\uc774 \ud3f0 \ube4c\ub808\ube0c\ub780\ud2b8\ubcd1(von Willebrand disease, VWD), 42,573\uba85\uc774 \uae30\ud0c0 \ucd9c\ud608\uc131 \uc9c8\ud658\uc744 \uc553\uace0 \uc788\ub294 \uac83\uc73c\ub85c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. \ub354\uc6b1\uc774, \uad6d\ub9bd\ud608\uc6b0\ubcd1\uc7ac\ub2e8(National Hemophilia Foundation)\uc5d0 \ub530\ub974\uba74, \uc804 \uc138\uacc4 \ud608\uc6b0\ubcd1 \ud658\uc790\uc758 \uc57d 75%\uac00 \uc5ec\uc804\ud788 \uc801\uc808\ud55c \uce58\ub8cc\ub97c \ubc1b\uc9c0 \ubabb\ud558\uac70\ub098 \uce58\ub8cc\uc5d0 \uc811\uadfc\ud560 \uc218 \uc5c6\ub294 \uc0c1\ud669\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc774\ub7ec\ud55c \ubbf8\ucda9\uc871 \uc758\ub8cc \uc218\uc694\uc640 \ud608\uc561 \uad00\ub828 \uc9c8\ud658 \uce58\ub8cc\uc758 \ud544\uc694\uc131 \uc99d\uac00, \uadf8\ub9ac\uace0 \uc804 \uc138\uacc4\uc801\uc778 \uc7ac\uc870\ud569 \uc81c\ud488 \uc0dd\uc0b0 \uc99d\uac00\ub294 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc7ac\uc870\ud569 \uc778\uc790 \ubd80\ubb38\uc758 \uafb8\uc900\ud55c \uc131\uc7a5\uc744 \uacac\uc778\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc7ac\uc870\ud569 \uc778\uc790 \ubd80\ubb38\uc740 \ub9e4\ucd9c \uae30\uc900\uc73c\ub85c \uc0c1\ub2f9\ud55c \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \ud5a5\ud6c4\uc5d0\ub3c4 \uc548\uc815\uc801\uc778 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n<p> 3.2. \ubd81\ubbf8 \uc9c0\uc5ed\uc758 \uc9c0\ubc30\uc801\uc778 \uc2dc\uc7a5 \uc810\uc720\uc728 \uc720\uc9c0<\/p>\n<p>\ubd81\ubbf8 \uc9c0\uc5ed\uc740 \ub2e4\uc591\ud55c \ud608\uc561 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\uc640 \ud658\uc790 \uc778\uad6c\uc758 \uc9c8\ubcd1 \uc778\uc2dd \uc99d\ub300\uc5d0 \ud798\uc785\uc5b4 \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\uc11c \uc8fc\uc694 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc608\uce21 \uae30\uac04\uc5d0\ub3c4 \uc774\ub7ec\ud55c \uc9c0\ubc30\uc801\uc778 \ucd94\uc138\ub97c \uc720\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc138\uacc4\ud608\uc6b0\ubcd1\uc5f0\ub9f9\uc5d0 \ub530\ub974\uba74, \ubbf8\uad6d\uc5d0\uc11c\ub9cc \uc57d 18,000\uba85\uc758 \ud608\uc6b0\ubcd1 \ud658\uc790\uc640 11,000\uba85 \uc774\uc0c1\uc758 \ud3f0 \ube4c\ub808\ube0c\ub780\ud2b8\ubcd1 \ud658\uc790\uac00 \uc874\uc7ac\ud569\ub2c8\ub2e4. \ud2b9\ud788 \ud608\uc6b0\ubcd1 A\ub294 \ub0a8\uc131 \ucd9c\uc0dd\uc544 5,000\uba85 \uc911 1\uba85\uc5d0\uac8c \uc601\ud5a5\uc744 \ubbf8\uce58\uba70, \ub9e4\ub144 \uc57d 400\uba85\uc758 \uc544\uae30\uac00 \ud608\uc6b0\ubcd1 A\ub97c \uac00\uc9c0\uace0 \ud0dc\uc5b4\ub098\ub294 \uac83\uc73c\ub85c \ubcf4\uace0\ub429\ub2c8\ub2e4.<\/p>\n<p>\ub610\ud55c, \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc \uc635\uc158 \uac1c\ubc1c\uc744 \uc704\ud55c \uc5f0\uad6c \uac1c\ubc1c(R&#038;D) \ud22c\uc790 \uc99d\uac00\uc640 \uc798 \uad6c\ucd95\ub41c \uc758\ub8cc \uc778\ud504\ub77c\uc758 \uc874\uc7ac\ub294 \uc774 \uc9c0\uc5ed \uc2dc\uc7a5\uc758 \uc804\ubc18\uc801\uc778 \uc131\uc7a5\uc744 \ud06c\uac8c \ucd09\uc9c4\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ubcf5\ud569\uc801\uc778 \uc694\uc778\ub4e4\uc774 \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\uc11c \uc120\ub450 \uc704\uce58\ub97c \uc720\uc9c0\ud558\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 4. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc5ec\ub7ec \uc8fc\uc694 \uae30\uc5c5\uc774 \ucc38\uc5ec\ud558\ub294 \ud30c\ud3b8\ud654\ub41c \uacbd\uc7c1 \uad6c\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. \uc2dc\uc7a5 \uc810\uc720\uc728 \uce21\uba74\uc5d0\uc11c\ub294 \uc18c\uc218\uc758 \uc8fc\uc694 \uae30\uc5c5\uc774 \ud604\uc7ac \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub4e4 \uae30\uc5c5\uc740 \ud601\uc2e0\uc801\uc778 \uce58\ub8cc\uc81c \uac1c\ubc1c\uacfc \uc2dc\uc7a5 \ud655\ub300\ub97c \ud1b5\ud574 \uacbd\uc7c1 \uc6b0\uc704\ub97c \ud655\ubcf4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uacbd\uc7c1\uc0ac\ub85c\ub294 Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi, Novo Nordisk A\/S, CSL Ltd, Pfizer Inc, Bayer AG, Celgene Corporation, Alexion Pharmaceuticals, Inc, Amgen Inc, AstraZeneca Plc \ub4f1\uc774 \uc788\uc73c\uba70, \uc774\ub4e4\uc740 \uc9c0\uc18d\uc801\uc778 \uc5f0\uad6c \uac1c\ubc1c\uacfc \uc804\ub7b5\uc801 \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud574 \uc2dc\uc7a5 \ub0b4 \uc785\uc9c0\ub97c \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 5. \uacb0\ub860<\/p>\n<p>\uae00\ub85c\ubc8c \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \ud608\uc561 \uc9c8\ud658\uc758 \ub192\uc740 \uc720\ubcd1\ub960, \uce58\ub8cc \uc811\uadfc\uc131 \uac1c\uc120 \ub178\ub825, \uadf8\ub9ac\uace0 \uc7ac\uc870\ud569 \uc778\uc790\uc640 \uac19\uc740 \ud601\uc2e0\uc801\uc778 \uce58\ub8cc\ubc95\uc758 \ubc1c\uc804\uc73c\ub85c \uc778\ud574 \uafb8\uc900\ud55c \uc131\uc7a5\uc744 \uc9c0\uc18d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ud2b9\ud788 \uc7ac\uc870\ud569 \uc778\uc790 \ubd80\ubb38\uacfc \ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uc774\ub7ec\ud55c \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud558\ub294 \ud575\uc2ec \ub3d9\ub825\uc73c\ub85c \uc791\uc6a9\ud560 \uac83\uc785\ub2c8\ub2e4. \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5\ub4e4\uc740 \ubbf8\ucda9\uc871 \uc758\ub8cc \uc218\uc694\ub97c \ud574\uacb0\ud558\uace0 \ud658\uc790\ub4e4\uc758 \uc0b6\uc758 \uc9c8\uc744 \ud5a5\uc0c1\uc2dc\ud0a4\uae30 \uc704\ud55c \uc9c0\uc18d\uc801\uc778 \ub178\ub825\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uc131\uc7a5 \uc7a0\uc7ac\ub825\uc744 \uadf9\ub300\ud654\ud560 \uac83\uc73c\ub85c \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n<p>\uae00\ub85c\ubc8c \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \ud608\uc561\uc758 \uc815\uc0c1\uc801\uc778 \uae30\ub2a5\uc5d0 \uc601\ud5a5\uc744 \ubbf8\uce58\ub294 \ub2e4\uc591\ud55c \uc9c8\ud658, \uc989 \ud608\uc18c\ud310, \ub2e8\ubc31\uc9c8, \uc601\uc591\uc18c\uc758 \uac10\uc18c \ub610\ub294 \uae30\ub2a5 \ubc29\ud574\ub97c \uc720\ubc1c\ud558\ub294 \uc9c8\ud658\uc5d0 \ub300\ud55c \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc744 \uc2ec\uce35\uc801\uc73c\ub85c \ubd84\uc11d\ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \ubc94\uc704\uc5d0\ub294 \ube48\ud608, \ud608\uc6b0\ubcd1\uacfc \uac19\uc740 \ucd9c\ud608\uc131 \uc9c8\ud658, \ub9bc\ud504\uc885, \ubc31\ud608\ubcd1, \uace8\uc218\uc885 \ub4f1 \uc8fc\uc694 \ud608\uc561\uc554\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4. \uc5f0\uad6c \uac00\uc815 \ubc0f \ubc94\uc704, \uadf8\ub9ac\uace0 \uc0c1\uc138\ud55c \uc5f0\uad6c \ubc29\ubc95\ub860\uc744 \ubc14\ud0d5\uc73c\ub85c \uc2dc\uc7a5 \uac1c\uc694, \ub3d9\uc778, \uc81c\uc57d \uc694\uc778, \uc138\ubd84\ud654, \uacbd\uc7c1 \ud658\uacbd, \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \ub3d9\ud5a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \uc815\ubcf4\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \uc5ed\ud559<br \/>\n\uae00\ub85c\ubc8c \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \ub3d9\uc778\uc73c\ub85c\ub294 \ub2e4\uc591\ud55c \ud608\uc561 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\uc640 \ucca8\ub2e8 \uce58\ub8cc \uc635\uc158 \uac1c\ubc1c\uc744 \uc704\ud55c \uc5f0\uad6c \uac1c\ubc1c(R&#038;D) \ud22c\uc790\uc758 \uc9c0\uc18d\uc801\uc778 \ud655\ub300\uac00 \uc788\uc2b5\ub2c8\ub2e4. \ubc18\uba74, \ub192\uc740 \uce58\ub8cc \ube44\uc6a9\uacfc \uac01\uad6d\uc758 \uc5c4\uaca9\ud55c \uaddc\uc81c\ub294 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uc81c\uc57d \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d(\uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825, \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825, \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611, \uacbd\uc7c1 \uac15\ub3c4)\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uc804\ubc18\uc801\uc778 \uacbd\uc7c1 \ud658\uacbd\uacfc \uad6c\uc870\ub97c \uc2ec\uce35\uc801\uc73c\ub85c \ud3c9\uac00\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654<br \/>\n\uc2dc\uc7a5\uc740 \uc138 \uac00\uc9c0 \uc8fc\uc694 \uae30\uc900\uc73c\ub85c \uc0c1\uc138\ud558\uac8c \uc138\ubd84\ud654\ub429\ub2c8\ub2e4.<br \/>\n1.  \uc81c\ud488 \uc720\ud615\ubcc4: \ud608\uc7a5 \uc720\ub798 \uc778\uc790(Plasma Derived Factors), \uc7ac\uc870\ud569 \uc778\uc790(Recombinant Factors), \uadf8\ub9ac\uace0 \uae30\ud0c0 \uc81c\ud488\uc73c\ub85c \ubd84\ub958\ub429\ub2c8\ub2e4.<br \/>\n2.  \uc751\uc6a9 \ubd84\uc57c\ubcc4: \ud608\uc0c9\uc18c \uc7a5\uc560(Hemoglobin Disorders), \ud608\uc18c\ud310 \uae30\ubc18 \uc7a5\uc560(Platelet Based Disorders), \ud608\uc7a5 \uc7a5\uc560(Plasma Disorders), \uace8\uc218 \uc99d\uc2dd\uc131 \uc7a5\uc560(Myeloproliferative Disorders), \uc720\uc804\uc131 \ud608\uc561 \uc9c8\ud658(Genetic Hematology Disorders), \ud608\uc561\uc554(Blood Cancers), \uadf8\ub9ac\uace0 \uae30\ud0c0 \uc751\uc6a9 \ubd84\uc57c\ub97c \ud3ec\ud568\ud558\uc5ec \uad11\ubc94\uc704\ud55c \uc9c8\ud658 \uc601\uc5ed\uc744 \ub2e4\ub8f9\ub2c8\ub2e4.<br \/>\n3.  \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ubc0f \uae30\ud0c0 \uc720\ub7fd \uad6d\uac00), \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud638\uc8fc, \ud55c\uad6d \ubc0f \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uad6d\uac00), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74(GCC, \ub0a8\uc544\ud504\ub9ac\uce74 \ubc0f \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uad6d\uac00), \ub0a8\ubbf8(\ube0c\ub77c\uc9c8, \uc544\ub974\ud5e8\ud2f0\ub098 \ubc0f \uae30\ud0c0 \ub0a8\ubbf8 \uad6d\uac00)\ub85c \uad6c\ubd84\ub418\uc5b4 \uac01 \uc9c0\uc5ed\ubcc4 \uc2dc\uc7a5 \ud2b9\uc131\uacfc \uc131\uc7a5 \uc7a0\uc7ac\ub825\uc744 \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<br \/>\n\ubcf4\uace0\uc11c\ub294 Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi, Novo Nordisk A\/S, CSL Ltd, Pfizer Inc, Bayer AG, Celgene Corporation, Alexion Pharmaceuticals, Inc, Amgen Inc, AstraZeneca Plc \ub4f1 \uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5\ub4e4\uc758 \uacbd\uc7c1 \ud658\uacbd\uc744 \uc0c1\uc138\ud788 \ubd84\uc11d\ud569\ub2c8\ub2e4. \uac01 \uae30\uc5c5\uc5d0 \ub300\ud574 \uc0ac\uc5c5 \uac1c\uc694, \uc7ac\ubb34 \uc131\uacfc, \uc8fc\uc694 \uc81c\ud488 \ubc0f \uc804\ub7b5, \uadf8\ub9ac\uace0 \ucd5c\uadfc \uac1c\ubc1c \ub3d9\ud5a5\uc744 \ud3ec\ud568\ud55c \ud3ec\uad04\uc801\uc778 \uc815\ubcf4\ub97c \uc81c\uacf5\ud558\uc5ec \uc2dc\uc7a5 \ub0b4 \uacbd\uc7c1 \uad6c\ub3c4\ub97c \uba85\ud655\ud788 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc804\ub9dd \ubc0f \uc608\uce21<br \/>\n\uae00\ub85c\ubc8c \ud608\uc561 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 6.13%\uc758 \uacac\uace0\ud55c \uc131\uc7a5\ub960(CAGR)\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4 \uc131\uc7a5 \uce21\uba74\uc5d0\uc11c\ub294 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ub192\uc740 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, 2025\ub144 \uae30\uc900\uc73c\ub85c\ub294 \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \ubd84\uc11d\ub429\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\ub294 2019\ub144\ubd80\ud130 2024\ub144\uae4c\uc9c0\uc758 \uacfc\uac70 \uc2dc\uc7a5 \uaddc\ubaa8 \ub370\uc774\ud130\uc640 \ud568\uaed8 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \uc0c1\uc138\ud55c \uc608\uce21 \uc2dc\uc7a5 \uaddc\ubaa8\ub97c \uc81c\uacf5\ud558\uc5ec \uc2dc\uc7a5\uc758 \ud604\uc7ac \uc0c1\ud0dc\uc640 \ubbf8\ub798 \uada4\uc801\uc744 \uba85\ud655\ud788 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-44648","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/44648"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=44648"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/44648\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=44648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=44648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=44648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}